SEC Form 4 · accession 0001654954-18-007267
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurence N Charney
Director
Period of report
Jun 26, 2018
Accepted (ET)
Jul 2, 2018 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF2 | Jun 26, 2018 | A | 15,000 | $0.00 | A | 118,949 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a grant of restricted shares that will vest on June 26, 2021.
- F2Includes shares of restricted Common Stock, which vest over various time periods.